[1]
S. B. Shrestha, M. Bhusal, J. Jwarchan, S. Gautam, and P. R. Shrestha, “Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients”, J Nepal Health Res Counc, vol. 20, no. 4, pp. 881-885, Jul. 2023.